Nice find but what could they possibly be presenting when it comes to finance? How to completely fail at managing a public company, or possibly how to screw over thousands of shareholders and an entire region of those suffering from sickle cell? Who's paying for this?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.